Latest Voluntary Suspension News

Paradigm will return the US$2 million drawn from Obsidian earlier this month and cancel the associated convertible notes, without an additional payment. The decision comes as the biotechnology company reviews interim data from its pivotal knee osteoarthritis trial and prepares a separate update on funding and operations.

Nexsen has paused its StrepSure clinical programme after an interim review identified performance improvements needed before a US FDA submission, pushing the target timetable back by roughly one quarter. Its shares were then suspended pending an announcement about a potentially material contract for an additional device.

Paradigm Biopharmaceuticals has secured a voluntary suspension of its ASX securities while it prepares to release interim analysis results from its PARA_OA_012 Phase 3 trial. The announcement gives no indication whether the clinical readout is favourable or unfavourable, with trading potentially resuming on 28 September subject to ASX approval.

Flynn Gold has been suspended from trading while it prepares to announce a capital raising, leaving investors without details on the size, pricing or potential dilution. The company expects normal trading to resume by 18 September 2026, unless the announcement is released sooner.

Prestal Holdings Limited posted a 30% drop in sales to $10.3 million and a $3.6 million net loss for FY26, while exiting its core Hampers With Bite business in a strategic pivot.

Viridis Mining and Minerals Limited (ASX: VMM) has halted trading of its shares pending the release of its Definitive Feasibility Study results, with the suspension expected to last until 20 August 2026 or earlier if the announcement is made sooner.

Dateline Resources faces a US court injunction halting operations at its Colosseum Project, while ASX suspends and then reinstates trading over disclosure timing concerns.

Ozz Resources reported a $1.06 million loss for FY2025, deepening net liabilities and maintaining voluntary ASX suspension while advancing key exploration projects in Western Australia.

Sky Metals has voluntarily suspended its ASX-listed securities pending a material announcement regarding its Tallebung Tin-Tungsten-Silver Project, with trading expected to resume by 10 August or upon release of the news.

Radiopharm Theranostics (ASX: RAD) has requested an immediate voluntary suspension of its shares pending a material capital raising announcement expected before markets open on 27 July 2026.

Prestal Holdings Limited (ASX: PTL) has voluntarily suspended trading in its shares pending disclosure of a significant transaction. Details remain under wraps as the company complies with ASX requirements.

Lotus Resources confirms material operational setbacks at Kayelekera uranium project, including acid plant damage and production delays impacting offtake commitments. The company remains suspended pending critical funding arrangements.